Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign

Chest. 2020 Oct;158(4):1770-1776. doi: 10.1016/j.chest.2020.06.013. Epub 2020 Jun 17.

Abstract

Smoking is associated with one of five deaths in the United States. Multimodality tobacco treatment increases rates of successful cessation by at least 20%. The coronavirus disease 2019 pandemic has put a halt to many inpatient and outpatient medical visits that have been deemed nonessential, including tobacco treatment. The transition to telehealth has been wrought with challenges. Although data on the association between coronavirus disease 2019 and tobacco products are mixed, the overall health consequences of tobacco point towards increased risk of morbidity and death that is associated with the virus. This leaves smoking as one of the few readily modifiable risk factors in an environment understandably not set up to prioritize cessation. A military health facility on Fort Eustis in Virginia runs a successful tobacco treatment program and adapted it to pandemic times. This article describes the process and lessons learned from this initiative. The model is applicable and scalable to government and civilian health centers as health care adapts to a new normal.

Keywords: COVID-19; pandemic; public health; smoking cessation; tobacco treatment.

Publication types

  • Review

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / epidemiology*
  • Humans
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2
  • Smoking / psychology*
  • Smoking Cessation*
  • Smoking Prevention / organization & administration*
  • Tobacco Use Disorder / prevention & control*